Jiménez, N., Rodriguez-Vida, A., & Mellado, B. (2024). Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients.
Chicago Style CitationJiménez, Natalia, Alejo Rodriguez-Vida, and Begoña Mellado. Development and Independent Validation of a Prognostic Gene Expression Signature Based On RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. 2024.
MLA CitationJiménez, Natalia, Alejo Rodriguez-Vida, and Begoña Mellado. Development and Independent Validation of a Prognostic Gene Expression Signature Based On RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients. 2024.
Warning: These citations may not always be 100% accurate.